skip to content

EPSRC IRC in Targeted Delivery for Hard-to-Treat Cancers

 

We aim to validate the technologies developed in several different scenarios, including

  • Implantable devices and injectable gels to treat inoperable brain tumours

  • Injectable gels to fill the cavity following brain tumour resection

  • Locally-applied supramolecular vehicle suspensions and gels for mesothelioma

  • Systemically administered supramolecular vehicles for pancreatic cancer